Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Saunders

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Human Mutation|October 19, 2022
Using single molecule Molecular Inversion Probes as a cost-effective, high-throughput sequencing approach to target all genes and loci associated with macular diseasesRebekkah J Hitti-Malin, Claire-Marie Dhaenens, Daan M Panneman, et al.
ALTEX|September 13, 2022
Development of an Evidence-Based Risk Assessment FrameworkDaniel Krewski, Patrick Saunders-Hastings, Robert A Baan, et al.
Vaccine|November 20, 2022
Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in the United States, 2019-2020Keran Moll, Bradley Lufkin, Kathryn R Fingar, et al.
Frontiers in Cell and Developmental Biology|February 23, 2023
Cost-effective sequence analysis of 113 genes in 1,192 probands with retinitis pigmentosa and Leber congenital amaurosisDaan M Panneman, Rebekkah J Hitti-Malin, Lara K Holtes, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Human Mutation|October 19, 2022
Using single molecule Molecular Inversion Probes as a cost-effective, high-throughput sequencing approach to target all genes and loci associated with macular diseasesRebekkah J Hitti-Malin, Claire-Marie Dhaenens, Daan M Panneman, et al.
ALTEX|September 13, 2022
Development of an Evidence-Based Risk Assessment FrameworkDaniel Krewski, Patrick Saunders-Hastings, Robert A Baan, et al.
Vaccine|November 20, 2022
Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in the United States, 2019-2020Keran Moll, Bradley Lufkin, Kathryn R Fingar, et al.
Frontiers in Cell and Developmental Biology|February 23, 2023
Cost-effective sequence analysis of 113 genes in 1,192 probands with retinitis pigmentosa and Leber congenital amaurosisDaan M Panneman, Rebekkah J Hitti-Malin, Lara K Holtes, et al.
Pageof 5